| FVIFX | VMVAX | FVIFX / VMVAX | |
| Total Expense Ratio | 0.90 | 0.07 | 1,286% |
| Annual Report Gross Expense Ratio | 0.92 | 0.07 | 1,314% |
| Fund Existence | 22 years | 14 years | - |
| Gain YTD | 4.194 | 11.046 | 38% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 331M | 32.6B | 1% |
| Annual Yield % from dividends | 0.86 | 2.14 | 40% |
| Returns for 1 year | 3.66 | 9.63 | 38% |
| Returns for 3 years | 23.64 | 32.97 | 72% |
| Returns for 5 years | 47.18 | 54.00 | 87% |
| Returns for 10 years | 87.05 | 109.34 | 80% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OARDX | 26.90 | 0.09 | +0.34% |
| Invesco Rising Dividends A | |||
| SMVFX | 11.27 | 0.02 | +0.18% |
| Virtus Ceredex Mid-Cap Value Equity C | |||
| APDKX | 53.67 | 0.05 | +0.09% |
| Artisan International Value Advisor | |||
| ETAMX | 14.38 | N/A | N/A |
| Eventide Balanced Fund Class A | |||
| DIEAX | 47.19 | -0.06 | -0.13% |
| BNY Mellon International Core Equity A | |||